887 Ribosomal protein L30p/L7e
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 25 | 12.6 | 1.99× | q < 0.0001 | |
| Homogeneous non-metal compounds | 1 | 5.5 | 0.18× | q = 0.05 | |
| Nucleosides, nucleotides, and analogues | 0 | 7.1 | 0 | q = 1.4e-3 | |
| Organic oxygen compounds | 0 | 5.1 | 0 | q = 0.01 | |
| Mixed metal/non-metal compounds | 1 | 0.5 | 1.86× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
No DrugBank compounds are annotated on this group's domains.
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 763 |
| OHX | osmium (III) hexammine | 71 |
| PUT | 1,4-DIAMINOBUTANE | 7 |
| CL | CHLORIDE ION | 4 |
| Kmetal | POTASSIUM ION | 3 |
| NMY | NEOMYCIN | 2 |
| PAR | PAROMOMYCIN | 2 |
| UNX | UNKNOWN ATOM OR ION | 2 |
| MNmetal | MANGANESE (II) ION | 1 |